Hepatic loss of CerS2 induces cell division defects via a mad2‐mediated pathway
Authors:
Open Access
- 28 January 2022
- journal article
- research article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 12 (1) , e712
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2018YFA0506900, 2018YFA0800900)
This publication has 10 references indexed in Scilit:
- A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19Nature Metabolism, 2021
- Clinical and pathological significance ofHomo sapiensceramide synthase 2 (CerS-2) in diverse human cancersBioscience Reports, 2019
- CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin ResistanceCell Metabolism, 2014
- Polyploidization in Liver TissueThe American Journal of Pathology, 2014
- Ceramide synthases at the centre of sphingolipid metabolism and biologyBiochemical Journal, 2012
- Chain length-specific properties of ceramidesProgress in Lipid Research, 2012
- Mad2 inhibits the mitotic kinesin MKlp2Journal of Cell Biology, 2010
- A Critical Role for Ceramide Synthase 2 in Liver HomeostasisJournal of Biological Chemistry, 2010
- Ceramide Synthases: Roles in Cell Physiology and Signaling2010
- Thematic Review Series: Sphingolipids. Nuclear sphingolipids: metabolism and signalingJournal of Lipid Research, 2008